Table 1.
Resistance profile of clinical isolates.
| Isolate | Resistance phenotype |
|||||||
|---|---|---|---|---|---|---|---|---|
| AUG | CTX | CAZ | MER | ESBL | CIP | AMI | GEN | |
| Escherichia coli 2004-1 | S | S | S | S | – | S | S | S |
| E. coli 2004-8 | S | S | S | S | – | S | S | S |
| E. coli 2004-23 | R | S | S | S | – | R | S | S |
| E. coli 2004-49 | R | S | S | S | – | R | S | S |
| E. coli 2004-69 | R | I | R | S | NEG | R | S | S |
| E. coli 2004-62 | R | S | S | S | – | S | S | S |
| E. coli 2005-1 | S | S | S | S | – | S | S | S |
| E. coli 2005-13 | R | S | R | S | NEG | S | S | R |
| E. coli 2005-19 | R | S | S | S | – | R | S | S |
| E. coli 2005-72 | I | S | S | S | – | S | S | S |
| E. coli 235663 | R | R | R | S | POS | R | S | S |
| E. coli 237088 | R | S | S | S | NEG | R | S | S |
| E. coli 238727 | R | R | S | S | POS | R | S | S |
| E. coli 238728 | R | R | S | S | POS | R | S | S |
| E. coli 14815 | R | R | R | S | POS | R | S | R |
| E. coli 232227 | R | R | R | S | POS | S | S | R |
| E. coli 28265 | R | R | R | S | POS | R | S | R |
| Klebsiella pneumoniae 207.2 | R | R | R | R | POS | R | S | R |
| K. pneumoniae 234933 | R | S | R | S | NEG | R | S | S |
| K. pneumoniae 26752 | R | S | R | S | NEG | S | S | S |
| Enterobacter spp. 15584 | R | R | R | S | POS | R | S | R |
| Enterobacter spp. 235204 | R | R | R | S | NEG | R | S | S |
| Enterobacter spp. 235797 | R | R | R | S | POS | I | S | R |
| Enterobacter spp. 236508 | R | R | R | S | POS | R | S | S |
| Enterobacter spp. 236878 | R | R | R | S | POS | S | S | R |
| Enterobacter spp. 32475 | R | R | R | S | NEG | S | S | S |
| Acinetobacter genospecies 3 103165 | – | R | S | R | – | S | S | S |
| Acinetobacter baumannii 229437 | – | R | R | R | – | R | R | R |
| Pseudomonas aeruginosa 3 | – | – | – | R | – | R | S | R |
| P. aeruginosa 53 | – | – | – | S | – | R | S | R |
| Stenotrophomonas maltophilia 15251 | R | R | R | R | – | R | R | R |
| S. maltophilia 89847 | R | R | R | R | – | S | R | R |
AUG, Augmentin (amoxicillin/clavulanic acid); CTX, cefotaxime; CAZ, ceftazidime; MER, meropenem; ESBL, extended–spectrum β–lactamase; CIP, ciprofloxacin; AMI, amikacin; GEN, gentamicin; NEG, negative; POS, positive; R, resistant; S, sensitive; I, intermediate.